Medicare Enrolled
Dr. Mateen Aliniazee, M.D.
Ophthalmology · Elmhurst, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aliniazee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aliniazee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aliniazee
Dr. Mateen Aliniazee is an ophthalmology specialist in Elmhurst, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Aliniazee performed 2,560 Medicare services across 1,945 unique beneficiaries.
Between the years covered by Open Payments, Dr. Aliniazee received a total of $117,361 from 48 pharmaceutical and/or device companies across 662 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aliniazee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 41% volume in IL
$117,361 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,560
Medicare services
Top 41% in IL for ophthalmology
1,945
Unique beneficiaries
$113
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~135 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
431 | $30 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
422 | $91 | $220 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
314 | $64 | $150 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
263 | $31 | $150 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
230 | $392 | $1,400 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
202 | $258 | $550 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
191 | $115 | $220 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
146 | $27 | $100 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
116 | $46 | $100 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
109 | $28 | $100 |
| Laser repair to improve eye fluid flow A laser procedure used to enhance the drainage of fluid within the eye. |
39 | $171 | $800 |
| Laser eye fluid drainage tract creation A laser procedure used to create drainage tracts in the iris to help fluid flow out of the eye. |
27 | $196 | $600 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
25 | $81 | $150 |
| Incision to improve eye fluid flow A surgical procedure involving an incision to enhance the drainage of fluid within the eye. |
23 | $618 | $1,150 |
| Cataract removal with artificial lens and drainage device insertion Surgical removal of the eye's natural lens followed by the insertion of an artificial lens and a drainage device into the front chamber of the eye. |
22 | $256 | $1,600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.0% high complexity
22.5% medium
68.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$117,361
Total received (2018-2024)
Avg $16,766/year across 7 years
Top 3% in IL for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
662
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$93,401 (79.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,182 (15.5%)
Other
Charitable contributions, space rental, and other categories
$4,492 (3.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,286 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,038
2023
$4,004
2022
$8,406
2021
$94,487
2020
$2,124
2019
$3,268
2018
$2,034
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$626
Bausch & Lomb Americas Inc.
$373
SUN PHARMACEUTICAL INDUSTRIES INC.
$316
BIOTISSUE HOLDINGS INC.
$221
Amgen Inc.
$189
RxSight Inc
$179
Harrow Eye, LLC
$179
Johnson & Johnson Surgical Vision, Inc.
$173
Alcon Vision LLC
$169
Glaukos Corporation
$147
Oyster Point Pharma, Inc.
$127
ANI Pharmaceuticals, Inc.
$121
Tarsus Pharmaceuticals, Inc.
$78
Thea Pharma Inc.
$46
Sight Sciences, Inc.
$39
Dompe US, Inc.
$29
Rayner Intraocular Lenses Limited
$26
Top 3 companies account for 43.3% of 2024 payments
All-time payments by company (2018-2024) ›
Eyevance Pharmaceuticals LLC
$93,604
Carl Zeiss Meditec USA, Inc.
$4,724
Johnson & Johnson Surgical Vision, Inc.
$3,055
Novartis Pharmaceuticals Corporation
$1,426
RxSight Inc
$1,396
Carl Zeiss Meditec, Inc.
$1,332
Bausch & Lomb, a division of Bausch Health US, LLC
$1,075
Alcon Vision LLC
$1,054
Bausch & Lomb Americas Inc.
$948
Allergan, Inc.
$936
ABBVIE INC.
$814
GLAUKOS CORPORATION
$593
Aerie Pharmaceuticals, Inc.
$538
Glaukos Corporation
$502
AbbVie Inc.
$465
Oyster Point Pharma, Inc.
$417
Sight Sciences, Inc.
$414
Beaver-Visitec International, Inc.
$382
SUN PHARMACEUTICAL INDUSTRIES INC.
$359
Sun Pharmaceutical Industries Inc.
$337
Horizon Therapeutics plc
$306
Allergan Inc.
$266
Dompe US, Inc.
$242
BIOTISSUE HOLDINGS INC.
$221
Harrow Eye, LLC
$203
Kala Pharmaceuticals, Inc.
$203
Amgen Inc.
$189
EYEVANCE PHARMACEUTICALS LLC
$170
Apellis Pharmaceuticals, Inc.
$153
Shire North American Group Inc
$145
Thea Pharma Inc.
$132
ANI Pharmaceuticals, Inc.
$121
Akorn Operating Company LLC
$113
STAAR SURGICAL COMPANY
$89
Tarsus Pharmaceuticals, Inc.
$78
Integra LifeSciences Corporation
$65
Ocular Therapeutix, Inc.
$53
Avedro Inc.
$45
TISSUETECH, INC.
$34
Rayner Intraocular Lenses Limited
$26
NEW WORLD MEDICAL,INC.
$24
Iridex Corporation
$21
BIOTISSUE HOLDINGS, INC.
$21
Carl Zeiss Meditec AG
$19
Ivantis, Inc
$15
TissueTech, Inc.
$13
Genentech USA, Inc.
$12
Regeneron Healthcare Solutions, Inc.
$11
Top 3 companies account for 86.4% of all-time payments
Associated products mentioned in payments ›
ALPHAGAN P · AMVISC · ARGOS · AcrySof · AcrySof IQ PanOptix · AcrySof IQ VIVITY IOL · Ahmed Glaucoma Valve · BIOFIX · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CATALYS SYSTEM · CEQUA · COMBIGAN · Catalys Laser System · Cequa · Clareon · DEXTENZA · DUREZOL · DURYSTA · ENVISTA · EYLEA AFLIBERCEPT INJECTION · Flarex · HYDRUS Microstent · Hydrus · IACCESS · INVELTYS · IOL · IOLMaster 500 · IOLMaster 700 · ISTENT · ISTENT INJECT W · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · IYUZEH · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX · LOTEMAX SM · LUMERA 700 · LUMIGAN · LenSx · MIEBO · NGENUITY · None Specified · OMNI · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · OXERVATE · Ophthalmic Surgical Adjuncts · Oxervate · PROKERA · PROLENSA · PURIFIED CORTROPHIN GEL · Photrexa · Prokera · QUATERA 700 · RAYNER CATARACT SET 1 · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · ReSure Sealant · Rhopressa · Rocklatan · STELLARIS · SUSVIMO · Simbrinza · Syfovre · TEARCARE SYSTEM · TECNIS IOL · TEPEZZA · TRAVATAN Z · TYRVAYA · Tecnis 1-piece IOL · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · Tecnis Simplicity · Tecnis Symfony IOL · Tecnis iTec Preloaded Delivery System · TobraDex ST · Tobradex ST · VERITAS Vision System · VEVYE · VUITY · VYZULTA · VisuMax · Wavelight · XDEMVY · XELPROS · XEN · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · ZYLET · Zerviate · Zioptan · iDose · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (80%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 3% for ophthalmology in IL.
Geographic Context
Ophthalmologists within 10 mi
641
Per 100K population
69.1
County median income
$110,502
Nearest hospital
ELMHURST MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Aliniazee is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 3% of IL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Aliniazee experienced with retinal imaging (oct scan)?
Based on Medicare claims data, Dr. Aliniazee performed 431 retinal imaging (oct scan) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aliniazee receive payments from pharmaceutical companies?
Yes. Dr. Aliniazee received a total of $117,361 from 48 companies across 662 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aliniazee's costs compare to other ophthalmologists in Elmhurst?
Dr. Aliniazee's average Medicare payment per service is $113. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aliniazee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Elmhurst
Browse ophthalmologists in Elmhurst ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in IL
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in IL
Which IL ophthalmologists receive the most from drug and device companies.
By company
Eyevance Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Eyevance Pharmaceuticals LLC.
By company
Carl Zeiss Meditec USA, Inc. Payments to Doctors
See all physicians who received payments from Carl Zeiss Meditec USA, Inc.
By company
Johnson & Johnson Surgical Vision, Inc. Payments to Doctors
See all physicians who received payments from Johnson & Johnson Surgical Vision, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology